Epicentrx, Inc logo
VerifiedBiotechnology Research

Epicentrx, Inc

EpicentRx is an innovation-driven clinical-stage drug and device company that puts the emphasis on “ease” - ease of treatment, ease of side effects, and ease of symptoms during the treatment of a range of diseases including lung cancer, and head and neck cancer, and different inflammatory disorders for which the company has received several grants and orphan designations. The lead device is called the eLOOP and the lead therapies are the direct NLRP3 inhibitor, nibrozetone (RRx-001), and the TGF-β trap-enhanced oncolytic adenovirus, AdAPT-001, in Phase 3, and Phase 2 clinical trials, respectively.

7-day free trial · no credit card

HeadquartersLa Jolla, United StatesEmployees19(11 to 50)Annual revenue$1M to <$10MWebsiteepicentrx.comLinkedIn profileLinkedIn

Verified contacts

9

available on Kipplo

LinkedIn employees

19

11 to 50 range

Open roles

no listings

Distinct roles

7

indexed titles

Tech stack

0

tools in use

Monthly traffic

524

organic / mo

Sign up free to see all 9 verified contacts at Epicentrx, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

9 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Epicentrx, Inc

7 distinct titles indexed · top 7 shown.

  • 1(, -)
  • 1chief executive officer
  • 1director clinical operations
  • 1director of regulatory site operations
  • 1head of quality
  • 1senior project scientist
  • 1staff research assistant

Sign up to unlock all 9 contacts at Epicentrx, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 9 verified contacts at Epicentrx, Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Epicentrx, Inc | Kipplo Discover